Clincosm LogoSign in Get a demo

Photogrammetric Scan System for Body Composition Analysis

Sponsor
Istituto Ortopedico Galeazzi (Other)
Overall Status
Recruiting
CT.gov ID
NCT05864820
Collaborator
(none)
75
Enrollment
1
Location
23.5
Anticipated Duration (Months)
3.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This observational study evaluates the goodness of the IGOODI photogrammetric scan system in measuring anthropometry and estimating the body composition of 75 healthy subjects, comparing the results with the measurements taken using methods used in clinical practice, including body circumferences and bioimpedance analysis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    75 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Use of Photogrammetric Technology for the Evaluation of Anthropometric Measurements and Body Composition
    Actual Study Start Date :
    Apr 18, 2023
    Actual Primary Completion Date :
    May 8, 2023
    Anticipated Study Completion Date :
    Apr 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Correlation between anthropometric circumferences [Baseline and after 1 year]

      Association between the circumferences taken with clinical practice methodology (inelastic and flexible tape measure) and the results from the photogrammetric technology

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Male or female gender

    • Between the ages of 18 and 85

    • Caucasian race

    • Cognitively intact

    • Acceptance and signing of informed consent

    • Height between 120 and 200 cm (included)

    Exclusion Criteria:

    • Congenital or acquired musculoskeletal deformities of the limbs or trunk

    • Implants resulting from cosmetic surgery

    • Articular prostheses and/or means of synthesis

    • Current oncological or metabolic pathologies

    • Photosensitivity

    • Epilepsy

    • Claustrophobia

    • Subjects unable to independently maintain an upright position

    • Wearers of pacemakers

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IRCCS Istituto Ortopedico Galeazzi Milan Italy

    Sponsors and Collaborators

    • Istituto Ortopedico Galeazzi

    Investigators

    • Principal Investigator: Matteo Briguglio, IRCCS Istituto Ortopedico Galeazzi

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Istituto Ortopedico Galeazzi
    ClinicalTrials.gov Identifier:
    NCT05864820
    Other Study ID Numbers:
    • AVATARGET (PI: M Briguglio)
    • L3052
    First Posted:
    May 18, 2023
    Last Update Posted:
    May 18, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of May 18, 2023